선택적 제품 분석
허용하는 경우 개인정보 보호를 고려한 제한적 분석을 사용해 어떤 리서치 여정이 효과적인지 파악합니다. 광고 추적기나 세션 녹화는 사용하지 않습니다. 환경설정에서 이 선택을 변경할 수 있습니다. 자세한 내용은 개인정보 처리방침.
Aon plc's published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $58.5B | |
|---|---|---|
| Revenue (ttm) | 17.7B | |
| Net income (ttm) | 3.9B | |
| EPS (ttm) | $18.3 | |
| Shares out | 212.1M | |
| P/E (trailing) | 17.2x | |
| P/E (forward) | 13.5x | |
| Dividend | $3.28 (1.03%) | |
| Volume | 2,215,454 | |
| Beta | 0.69 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $12.19B | $12.48B | $13.38B | $15.70B | $17.18B | +9.0% |
| Gross profit | $5.46B | $6.00B | $6.47B | $7.42B | $8.20B | +10.7% |
| Operating income | $2.09B | $3.67B | $3.79B | $3.84B | $4.34B | +20.1% |
| Net income | $1.26B | $2.59B | $2.56B | $2.65B | $3.70B | +31.0% |
| EPS (diluted) | $5.55 | $12.14 | $12.51 | $12.49 | $17.02 | +32.3% |
| EBITDA | $2.58B | $3.83B | $3.79B | $4.94B | $5.35B | +20.0% |
| R&D | $0 | $0 | $0 | — | — | +22.5% |
| SG&A | $2.54B | $1.74B | $1.79B | $2.01B | $1.56B | -11.5% |
Recent company headlines from major financial publishers.
In the base case, Aon maintains its disciplined operational execution across core commercial broking and reinsurance placement, achieving mid-single-digit organic revenue expansion consistent with nominal global economic growth. Operating margin expansion aligns with management annual targets as enterprise service efficiencies offset specialized talent compensation expenses. Share repurchases steadily reduce diluted share count, supporting intrinsic convergence toward $338.37 (labelled Fair value at $338.37) with an assigned probability of 60.0% and an implied upside of 22.6% relative to the price of $275.95. This outcome would be disconfirmed by multi-quarter deceleration in organic brokerage revenue or operating margin contraction below targeted levels by the end of FY2026.
In the bull case, expanding complex global risk exposures and strong commercial property and casualty pricing drive organic revenue expansion across Risk Capital and Human Capital. Enhanced operational efficiencies from enterprise analytics platforms expand operating profitability, accelerating free cash flow conversion and funding expanded share repurchases. Under these conditions, the shares project toward $419.70 with an estimated probability of 15.0%, offering an implied return of 52.1% from the analysis price of $275.95. This path requires sustained client demand across emerging risk categories such as data infrastructure, and would be disconfirmed if corporate insurance rate softening emerges before the conclusion of FY2027.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 7.1% | $361 | $369 | $378 | $388 | $400 |
| 7.6% | $342 | $349 | $356 | $363 | $372 |
| 8.1% | $326 | $331 | $338 | $343 | $350 |
| 8.6% | $312 | $316 | $321 | $326 | $331 |
| 9.1% | $300 | $303 | $307 | $311 | $316 |
Upcoming earnings date and setup when available.
매월 발행된 리서치 판이 부여한 등급입니다. 등급은 분석 시점의 가격을 공정 가치와 비교한 것이며, 판단이 맞았는지에 대한 기록이 아닙니다.
| 연도 | 1월 | 2월 | 3월 | 4월 | 5월 | 6월 | 7월 | 8월 | 9월 | 10월 | 11월 | 12월 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |